Skip to content
Preprint · OA via OpenAlex

Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism

Ivan Vujkovic-Cvijin, Richard M. Dunham, Shoko Iwai, Michael C. Maher, Rebecca G. Albright, Mara Jana Broadhurst, Ryan D. Hernandez, Michael M. Lederman, Yong Huang, Ma Somsouk, Steven G. Deeks, Peter W. Hunt, Susan V. Lynch, J M McCune

Science Translational Medicine · 2013 · ▲ 740 citations

Abstract

Progressive HIV infection is characterized by dysregulation of the intestinal immune barrier, translocation of immunostimulatory microbial products, and chronic systemic inflammation that is thought to drive progression of disease to AIDS. Elements of this pathologic process persist despite viral suppression during highly active antiretroviral therapy (HAART), and drivers of these phenomena remain poorly understood. Disrupted intestinal immunity can precipitate dysbiosis that induces chronic inflammation in the mucosa and periphery of mice. However, putative microbial drivers of HIV-associated immunopathology versus recovery have not been identified in humans. Using high-resolution bacterial community profiling, we identified a dysbiotic mucosal-adherent community enriched in Proteobacteria and depleted of Bacteroidia members that was associated with markers of mucosal immune disruption, T cell activation, and chronic inflammation in HIV-infected subjects. Furthermore, this dysbiosis was evident among HIV-infected subjects undergoing HAART, and the extent of dysbiosis correlated with activity of the kynurenine pathway of tryptophan catabolism and plasma concentrations of the inflammatory cytokine interleukin-6 (IL-6), two established markers of disease progression. Gut-resident bacteria with capacity to catabolize tryptophan through the kynurenine pathway were found to be enriched in HIV-infected subjects, strongly correlated with kynurenine levels in HIV-infected subjects, and capable of kynurenine production in vitro. These observations demonstrate a link between mucosal-adherent colonic bacteria and immunopathogenesis during progressive HIV infection that is apparent even in the setting of viral suppression during HAART. This link suggests that gut-resident microbial populations may influence intestinal homeostasis during HIV disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1126/scitranslmed.3006438
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Vujkovic-Cvijin, I., Dunham, R.M., Iwai, S., Maher, M.C., Albright, R.G., Broadhurst, M.J., Hernandez, R.D., Lederman, M.M., Huang, Y., Somsouk, M., Deeks, S.G., Hunt, P.W., Lynch, S.V., &amp; McCune, J.M. (2013). Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism. <em>Science Translational Medicine</em>. https://doi.org/10.1126/scitranslmed.3006438
Vancouver
Vujkovic-Cvijin I, Dunham RM, Iwai S, Maher MC, Albright RG, Broadhurst MJ, et al. Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism. Science Translational Medicine. 2013. doi:10.1126/scitranslmed.3006438.
BibTeX
@unpublished{ivan2013Dysbio, title = {Dysbiosis of the Gut Microbiota Is Associated with HIV Disease Progression and Tryptophan Catabolism}, author = {Ivan Vujkovic-Cvijin and Richard M. Dunham and Shoko Iwai and Michael C. Maher and Rebecca G. Albright and Mara Jana Broadhurst and Ryan D. Hernandez and Michael M. Lederman and Yong Huang and Ma Somsouk and Steven G. Deeks and Peter W. Hunt and Susan V. Lynch and J M McCune}, journal = {Science Translational Medicine}, year = {2013}, doi = {10.1126/scitranslmed.3006438}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings